208 related articles for article (PubMed ID: 16918922)
1. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
Wang H; Zhao H
Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
[TBL] [Abstract][Full Text] [Related]
2. A study on confidence intervals for incremental cost-effectiveness ratios.
Wang H; Zhao H
Biom J; 2008 Aug; 50(4):505-14. PubMed ID: 18663759
[TBL] [Abstract][Full Text] [Related]
3. On estimating medical cost and incremental cost-effectiveness ratios with censored data.
Zhao H; Tian L
Biometrics; 2001 Dec; 57(4):1002-8. PubMed ID: 11764238
[TBL] [Abstract][Full Text] [Related]
4. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Zwanziger J; Hall WJ; Dick AW; Zhao H; Mushlin AI; Hahn RM; Wang H; Andrews ML; Mooney C; Wang H; Moss AJ
J Am Coll Cardiol; 2006 Jun; 47(11):2310-8. PubMed ID: 16750701
[TBL] [Abstract][Full Text] [Related]
5. Regression methods for cost-effectiveness analysis with censored data.
Willan AR; Lin DY; Manca A
Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137
[TBL] [Abstract][Full Text] [Related]
6. Nonparametric statistical methods for cost-effectiveness analyses.
Dinh P; Zhou XH
Biometrics; 2006 Jun; 62(2):576-88. PubMed ID: 16918923
[TBL] [Abstract][Full Text] [Related]
7. Incremental net benefit in randomized clinical trials.
Willan AR; Lin DY
Stat Med; 2001 Jun; 20(11):1563-74. PubMed ID: 11391688
[TBL] [Abstract][Full Text] [Related]
8. On the equivalence of some medical cost estimators with censored data.
Zhao H; Bang H; Wang H; Pfeifer PE
Stat Med; 2007 Oct; 26(24):4520-30. PubMed ID: 17380543
[TBL] [Abstract][Full Text] [Related]
9. Incremental net benefit in randomized clinical trials with quality-adjusted survival.
Willan AR; Chen EB; Cook RJ; Lin DY
Stat Med; 2003 Feb; 22(3):353-62. PubMed ID: 12529868
[TBL] [Abstract][Full Text] [Related]
10. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
11. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
[TBL] [Abstract][Full Text] [Related]
12. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
Willan AR; Briggs AH; Hoch JS
Health Econ; 2004 May; 13(5):461-75. PubMed ID: 15127426
[TBL] [Abstract][Full Text] [Related]
13. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
Pullenayegum EM; Willan AR
Stat Med; 2007 Jul; 26(17):3274-99. PubMed ID: 17309112
[TBL] [Abstract][Full Text] [Related]
14. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
16. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
Willan AR; O'Brien BJ
Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
[TBL] [Abstract][Full Text] [Related]
17. Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals.
Severens JL; De Boo TM; Konst EM
Int J Technol Assess Health Care; 1999; 15(3):608-14. PubMed ID: 10874387
[TBL] [Abstract][Full Text] [Related]
18. The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery.
Blough DK; Ramsey S; Sullivan SD; Yusen R;
Health Econ; 2009 Jan; 18(1):91-101. PubMed ID: 18435426
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness as an outcome in randomized clinical trials.
Hlatky MA; Owens DK; Sanders GD
Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
[TBL] [Abstract][Full Text] [Related]
20. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.
Chaudhary MA; Stearns SC
Stat Med; 1996 Jul; 15(13):1447-58. PubMed ID: 8841654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
